Literature DB >> 12506524

Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.

Luigi Tarantini1, Pompilio Faggiano, Michele Senni, Donata Lucci, Daniele Bertoli, Maurizio Porcu, Cristina Opasich, Luigi Tavazzi, Aldo Pietro Maggioni.   

Abstract

BACKGROUND: The aim of this study was to evaluate the clinical characteristics, 1-year prognosis and therapeutic approach of heart failure with a preserved left ventricular systolic function in a large multicenter registry of patients referred to specialized heart failure clinics.
METHODS: The study population consisted of 5164 outpatients (mean age 62 +/- 12 years, 78.8% male, 28.1% in NYHA functional class III-IV) with an available left ventricular ejection fraction (LVEF) measurement at the initial evaluation for enrollment in the Italian Network on Congestive Heart Failure. A 1-year follow-up was available for 2390 patients.
RESULTS: 2859 out of 5164 patients (55.4%) had an LVEF < 35%, 1618 (31.3%) had an LVEF between 35 and 45%, and 687 patients (13.3%) had an LVEF > 45%. Patients with an LVEF > 45% were significantly older, more often female and presented a significantly higher prevalence of a hypertensive etiology, obesity and atrial fibrillation. The severity of the clinical picture, as indicated by a lower prevalence of NYHA class III-IV (17.2 vs 35.6%, p = 0.001) and a third heart sound (14.8 vs 33.5%, p = 0.001), was less in patients with an LVEF > 45%. The therapeutic approach differed significantly, with a larger use of calcium antagonists and beta-blockers in patients with an LVEF > 45%, while ACE-inhibitors, diuretics and digoxin were more often prescribed to those with an impaired LVEF. The 1-year mortality and morbidity (all cause and congestive heart failure worsening hospitalizations) were significantly lower in patients with a preserved left ventricular systolic function compared to those with left ventricular systolic dysfunction (8.9 vs 18.8% for mortality, p = 0.001, and 8.3 vs 16.5% for hospital readmissions due to worsening congestive heart failure, p = 0.001, respectively).
CONCLUSIONS: Patients with congestive heart failure and a preserved left ventricular systolic function seem to constitute a distinct population not infrequently presenting even in the clinical setting of specialized heart failure clinics. Further studies are needed to establish a definitive and standardized diagnosis and the most appropriate therapy for congestive heart failure with a normal LVEF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12506524

Source DB:  PubMed          Journal:  Ital Heart J        ISSN: 1129-471X


  6 in total

1.  [Epidemiology and prognosis of heart failure].

Authors:  F Edelmann
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

2.  Central obesity: association with left ventricular dysfunction and mortality in the community.

Authors:  Khawaja Afzal Ammar; Margaret M Redfield; Douglas W Mahoney; Matthew Johnson; Steven J Jacobsen; Richard J Rodeheffer
Journal:  Am Heart J       Date:  2008-11       Impact factor: 4.749

Review 3.  Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects.

Authors:  Maurizio Galderisi
Journal:  Cardiovasc Ultrasound       Date:  2005-04-04       Impact factor: 2.062

Review 4.  Mortality in heart failure patients.

Authors:  Ibadete Bytyçi; Gani Bajraktari
Journal:  Anatol J Cardiol       Date:  2014-08-19       Impact factor: 1.596

5.  Performance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides.

Authors:  Mitsuaki Sawano; Yasuyuki Shiraishi; Shun Kohsaka; Toshiyuki Nagai; Ayumi Goda; Atsushi Mizuno; Yasumori Sujino; Yuji Nagatomo; Takashi Kohno; Toshihisa Anzai; Keiichi Fukuda; Tsutomu Yoshikawa
Journal:  ESC Heart Fail       Date:  2018-03-09

6.  Readmission rates following heart failure: a scoping review of sex and gender based considerations.

Authors:  Amy Hoang-Kim; Camilla Parpia; Cassandra Freitas; Peter C Austin; Heather J Ross; Harindra C Wijeysundera; Karen Tu; Susanna Mak; Michael E Farkouh; Louise Y Sun; Michael J Schull; Robin Mason; Douglas S Lee; Paula A Rochon
Journal:  BMC Cardiovasc Disord       Date:  2020-05-14       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.